Using data from the FREEDOM (Future Revascularizaiton Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease) trial, the authors developed an 8 variable model that predicts individual risk of major acute cardiovascular events in diabetic patients with multivessel disease. Percutaneous coronary intervention (PCI) never outperformed CABG; the latter was superior to PCI in 54% of patients overall and in 100% of those who smoked.
You are here:
Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease
Submitted by: Mark Ferguson
Source: Journal of the American College of Cardiology
Source URL: http://www.onlinejacc.org/content/74/16/2074
Keywords:
Author(s): Mohammed Qintar, Karin H. Humphries, Julie E. Park, Suzanne V. Arnold, Yuanyuan Tang, Phillip Jones, Adam C. Salisbury, Faraz Kureshi, Michael E. Farkouh, Valentin Fuster, David J. Cohen and John A. Spertus
